Credit Suisse’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.1M | Buy |
100,354
+9,398
| +10% | +$291K | ﹤0.01% | 1578 |
|
|
2023
Q4 | $3.67M | Sell |
90,956
-631,783
| -87% | -$25.5M | ﹤0.01% | 1507 |
|
|
2023
Q3 | $19.1M | Sell |
722,739
-46,007
| -6% | -$1.21M | 0.02% | 649 |
|
|
2023
Q2 | $13.2M | Buy |
768,746
+35,918
| +5% | +$618K | 0.01% | 793 |
|
|
2023
Q1 | $12.2M | Buy |
732,828
+214,727
| +41% | +$3.56M | 0.01% | 838 |
|
|
2022
Q4 | $3.95M | Sell |
518,101
-90,927
| -15% | -$693K | ﹤0.01% | 1439 |
|
|
2022
Q3 | $6.05M | Buy |
609,028
+36,458
| +6% | +$362K | 0.01% | 1135 |
|
|
2022
Q2 | $5.2M | Sell |
572,570
-42,955
| -7% | -$390K | 0.01% | 1246 |
|
|
2022
Q1 | $6.25M | Sell |
615,525
-54,211
| -8% | -$550K | 0.01% | 1308 |
|
|
2021
Q4 | $11.2M | Buy |
669,736
+202,610
| +43% | +$3.38M | 0.01% | 1041 |
|
|
2021
Q3 | $21.9M | Buy |
467,126
+75,118
| +19% | +$3.52M | 0.01% | 777 |
|
|
2021
Q2 | $23.9M | Buy |
392,008
+25,029
| +7% | +$1.53M | 0.01% | 769 |
|
|
2021
Q1 | $22.6M | Buy |
366,979
+27,919
| +8% | +$1.72M | 0.01% | 809 |
|
|
2020
Q4 | $24.1M | Sell |
339,060
-123,027
| -27% | -$8.75M | 0.01% | 759 |
|
|
2020
Q3 | $17.3M | Sell |
462,087
-84,914
| -16% | -$3.19M | 0.01% | 803 |
|
|
2020
Q2 | $17.8M | Buy |
547,001
+536,945
| +5,340% | +$17.5M | 0.01% | 778 |
|
|
2020
Q1 | $292K | Sell |
10,056
-12,176
| -55% | -$354K | ﹤0.01% | 2841 |
|
|
2019
Q4 | $780K | Buy |
+22,232
| New | +$780K | ﹤0.01% | 2665 |
|
|
2019
Q3 | – | Sell |
-26,000
| Closed | -$701K | – | 3426 |
|
|
2019
Q2 | $701K | Buy |
+26,000
| New | +$701K | ﹤0.01% | 2585 |
|